Marcel Alexander Kamp
Overview
Explore the profile of Marcel Alexander Kamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roder C, Stummer W, Coburger J, Scherer M, Haas P, von der Brelie C, et al.
J Clin Oncol
. 2023 Jun;
41(36):5512-5523.
PMID: 37335962
Purpose: Prospective data suggested a superiority of intraoperative MRI (iMRI) over 5-aminolevulinic acid (5-ALA) for achieving complete resections of contrast enhancement in glioblastoma surgery. We investigated this hypothesis in a...
2.
Rapp M, von Sass C, Backhaus C, Hanggi D, Kamp M, Sabel M
Support Care Cancer
. 2022 Jan;
30(5):3985-3993.
PMID: 35061098
Purpose: Overall survival of malignant brain tumour patients has significantly been increased over the last years. However, therapy remains palliative, and side effects should be balanced. Once terminal phase is...
3.
Koch K, Hartmann R, Suwala A, Rios D, Kamp M, Sabel M, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885110
Cancer stem-like cells mediate tumor initiation, progression, and therapy resistance; however, their identification and selective eradication remain challenging. Herein, we analyze the metabolic dependencies of glioblastoma stem-like cells (GSCs) with...
4.
Staub-Bartelt F, Hofmann B, Rapp M, Hanggi D, Kamp M, Sabel M
World Neurosurg
. 2021 Apr;
150:147-152.
PMID: 33819710
Background: Intraoperative neuromonitoring (IONM) is widely used for elective resection of eloquently located brain tumors to increase safety and extent of resection. Owing to the need for specially trained personnel...
5.
Vargas-Toscano A, Nickel A, Li G, Kamp M, Muhammad S, Leprivier G, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33371210
Glioblastoma (GBM) is a lethal disease with limited clinical treatment options available. Recently, a new inhibitor targeting the prominent cancer signaling pathway mTOR was discovered (Rapalink-1), but its therapeutic potential...
6.
Herrera-Rios D, Li G, Khan D, Tsiampali J, Nickel A, Aretz P, et al.
Sci Rep
. 2020 Oct;
10(1):16218.
PMID: 33004830
The Notch signaling network determines stemness in various tissues and targeting signaling activity in malignant brain cancers by gamma-secretase inhibitors (GSI) has shown promising preclinical success. However, the clinical translation...
7.
Vargas-Toscano A, Khan D, Nickel A, Hewera M, Kamp M, Fischer I, et al.
CNS Oncol
. 2020 May;
9(2):CNS58.
PMID: 32462934
Glioblastoma is a heterogeneous lethal disease, regulated by a stem-cell hierarchy and the neurotransmitter microenvironment. The identification of chemotherapies targeting individual cancer stem cells is a clinical need. A robotic...
8.
Dibue-Adjei M, Kamp M, Vogelsang J, Wiltfang J, Wolff-Menzler C
Fortschr Neurol Psychiatr
. 2020 Jan;
88(1):40-51.
PMID: 31986551
Vagus nerve stimulation (VNS) is a minimally invasive neurostimulation method and was approved for drug-resistant epilepsy in children and adults in Europe in 1994. The observation that depression -the most...
9.
Meskelevicius D, Schafer A, Weber J, Hegmann L, Haddad L, Kamp M, et al.
Neurosurg Rev
. 2019 Mar;
43(2):633-642.
PMID: 30877481
Currently, there is no known time frame when the patients are the most responsive during awake craniotomy. The aim of this work is therefore to determine when the patient has...
10.
Dibue-Adjei M, Kamp M, Vonck K
Epilepsy Res
. 2019 Mar;
153:71-75.
PMID: 30824370
Neuromodulation therapies represent an important treatment arm for patients with drug-resistant epilepsy (DRE) who are not candidates for resective surgery. Vagus nerve stimulation (VNS) - the neurostimulation modality in focus...